Mostafa Yakoot

Alexandria University — Egypt

Medicine · Health Sciences

15h-index546citations45works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(17), Liver Disease Diagnosis and Treatment(8), Hepatitis B Virus Studies(6), HIV/AIDS drug development and treatment(6), COVID-19 Clinical Research Studies(3)

Publications45 total

Sildenafil in Emergency Treatment of Biliary Colic: A pilot randomized controlled trial
Research Square (Research Square)·2022Open Access
Sildenafil in Emergency Treatment of Biliary Colic: A pilot randomized controlled trial
2022Open Access
Clinical utility of repurposing a short course of hepatitis C drugs for COVID19. A randomized controlled study
2022Open Access
Nonsignificant trends in COVID‐19 trials: Is there a significance?
Journal of Medical Virology·2021· 4 citedOpen Access
Treatment of Chronic Hepatitis C in Adolescent Patients With Positive HBsAg or With Occult Hepatitis B: Is the Risk of Hepatitis B Reactivation Significant?
The Pediatric Infectious Disease Journal·2020· 4 cited
Follow‐up of chronic paediatric hepatitis C virus in a low‐/middle‐income country
Acta Paediatrica·2020· 5 cited
Efficacy and Safety of Sofosbuvir/Daclatasvir in the Treatment of COVID-19: A Randomized, Controlled Study
SSRN Electronic Journal·2020· 5 citedOpen Access
Effects of sofosbuvir/ledipasvir therapy on chronic hepatitis C virus genotype 4, infected children of 3‐6 years of age
Liver International·2019· 15 cited
Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study
SHILAP Revista de lepidopterología·2019Open Access
<p>Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study</p>
Diabetes Metabolic Syndrome and Obesity·2019· 7 citedOpen Access
Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy
World Journal of Clinical Cases·2019· 15 citedOpen Access
Effectiveness of 8-week sofosbuvir/ledipasvir in the adolescent chronic hepatitis C-infected patients
European Journal of Gastroenterology & Hepatology·2019· 18 cited
Effects of Sofosbuvir/Ledipasvir Therapy on Chronic HCV- Genotype-4, Infected Children of 3 to 6 Years of Age
SSRN Electronic Journal·2019· 1 citedOpen Access
Effects of Dual Sofosbuvir/Daclatasvir Therapy on Weight and Linear Growth in Adolescent Patients with Chronic Hepatitis C Virus Infection
The Pediatric Infectious Disease Journal·2018· 3 citedOpen Access
A pilot single arm observational study of sofosbuvir/ledipasvir (200 + 45 mg) in 6‐ to 12‐ year old children
Alimentary Pharmacology & Therapeutics·2018· 25 citedOpen Access
Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients With Chronic Hepatitis C Infection
Journal of Pediatric Gastroenterology and Nutrition·2018· 48 cited
Shortened 8 Weeks Course of Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients, With Chronic Hepatitis C Infection
Journal of Pediatric Gastroenterology and Nutrition·2017· 38 cited
Response Tailored Protocol Versus the Fixed 12 Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial
EBioMedicine·2017· 27 citedOpen Access
Very rapid virologic response and early HCV response kinetics, as quick measures to compare efficacy and guide a personalized response-guided therapy
Drug Design Development and Therapy·2016· 11 citedOpen Access
The very-rapid and the ultra-rapid virologic response to two treatment options in patients with chronic hepatitis C: an interim report of a prospective randomized comparative effectiveness study
Drug Design Development and Therapy·2015· 3 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Sherine Helmy(12), Mortada El‐Shabrawi(10), Amel Salem(9), Hisham R El‐Khayat(7), Enas Kamal(7), Abdel-Mohsen Omar(7), Alaa Abdo(6), Jianping Liu(6), Lixin Ma(6), Gunver S. Kienle(6), Anja Glockmann(6), Harald J. Hamre(6), Helmut Kiene(6), Dieter Melchart(6), Bernardino Clavo(6), Gerardo Suárez(6), Yolanda Aguilar(6), Dominga Gutiérrez(6), Alberto Cubero(6), Francisco Robaina(6)